Ligand Pharmaceuticals Incorporated (208) | Human Resources (7)
Browse by Subcategory
Recent Contracts
-
Form of Change in Control Severance Agreement
(Filed With SEC on May 8, 2023)
-
Amended and Restated Severance Plan, effective November 1, 2022
(Filed With SEC on February 28, 2023)
-
Separation Agreement , effective December 12, 2022, by and between Ligand Pharmaceuticals Incorporated and John Higgins
(Filed With SEC on February 28, 2023)
-
Severance Agreement, effective December 5, 2022, by and between Ligand Pharmaceuticals Incorporated and Todd C. Davis
(Filed With SEC on February 28, 2023)
-
2022 Employment Inducement Plan
(Filed With SEC on August 9, 2022)
-
Form of Performance-Based Restricted Stock Unit Award Agreement under the Companys 2022 Employment Inducement Plan
(Filed With SEC on August 9, 2022)
-
2002 Stock Incentive Plan (as amended and restated effective December 15, 2020)
(Filed With SEC on February 24, 2021)